These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Visceral leishmaniasis (kala-azar) and HIV infection. Apropos of a case and literature review]. Joggi J; Chave JP; Bruni D; Schmidt PM Schweiz Med Wochenschr; 1990 Mar; 120(12):414-6. PubMed ID: 2181645 [TBL] [Abstract][Full Text] [Related]
5. [Kala-azar in childhood]. Ballin A; Theodor R; Boichis H; Rotem Y; Altman G Harefuah; 1980 Jun; 98(11-12):501-3. PubMed ID: 7203192 [No Abstract] [Full Text] [Related]
6. [Visceral leishmaniasis and AIDS. Report of 2 cases with cutaneous dissemination]. Belda Mira A; Díaz Sánchez F; Martínez García B; Gonzalvo Bellver E; Antón Crespo V; Redón Mas J An Med Interna; 1994 Aug; 11(8):398-400. PubMed ID: 7772689 [TBL] [Abstract][Full Text] [Related]
7. [Visceral leishmaniasis (kala-azar) as an opportunistic infection in immunosuppressed patients]. Lüthy RM; Kistler HJ Schweiz Med Wochenschr; 1989 Sep; 119(38):1309-13. PubMed ID: 2587969 [TBL] [Abstract][Full Text] [Related]
8. [Is kala-azar a diagnostic criterion for acquired immunodeficiency syndrome?]. Yebra M; Segovia J; Montalbán C; Vargas JA Med Clin (Barc); 1989 Nov; 93(16):639. PubMed ID: 2615542 [No Abstract] [Full Text] [Related]
9. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit. Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133 [TBL] [Abstract][Full Text] [Related]
10. Digestive leishmaniasis in acquired immunodeficiency syndrome: a light and electron microscopic study of two cases. Zimmer G; Guillou L; Gauthier T; Iten A; Saraga EP Mod Pathol; 1996 Oct; 9(10):966-9. PubMed ID: 8902832 [TBL] [Abstract][Full Text] [Related]
11. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review. Hernández-Pérez J; Yebra-Bango M; Jiménez-Martínez E; Sanz-Moreno C; Cuervas-Mons V; Alonso Pulpón L; Ramos-Martínez A; Fernández-Fernández J Clin Infect Dis; 1999 Oct; 29(4):918-21. PubMed ID: 10589910 [TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis (kala-azar) in Fars Province, Iran: study of 130 cases. Hashemi-Nasab A; Zadeh-Shirazi H J Trop Med Hyg; 1980 Jun; 83(3):119-22. PubMed ID: 7401218 [TBL] [Abstract][Full Text] [Related]
14. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient. Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688 [TBL] [Abstract][Full Text] [Related]
15. A combination of sulphadiazine, trimethoprim and metronidazole or tinidazole in kala-azar. Bano P; Shahab SM J Assoc Physicians India; 1994 Jul; 42(7):535-6. PubMed ID: 7868522 [TBL] [Abstract][Full Text] [Related]
16. An atypical course of visceral leishmaniasis (Kala-azar) in a liver transplant recipient. Clemente WT; Couto CA; Ribeiro DD; de Medeiros Chaves França M; Sanches MD Transplantation; 2007 Feb; 83(3):368-9. PubMed ID: 17297421 [No Abstract] [Full Text] [Related]
17. [Visceral leishmaniasis in HIV-infected patients. A diagnostic criterion of AIDS?]. Flórez J; Vidal F; García-Queralt R; Richart C Rev Clin Esp; 1993 Mar; 192(5):249-50. PubMed ID: 8484047 [No Abstract] [Full Text] [Related]
18. Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome. Antinori S; Longhi E; Bestetti G; Piolini R; Acquaviva V; Foschi A; Trovati S; Parravicini C; Corbellino M; Meroni L Br J Dermatol; 2007 Nov; 157(5):1032-6. PubMed ID: 17854365 [TBL] [Abstract][Full Text] [Related]